Effects of interleukin-12 administration during the pre- and peri-implantation period on mouse embryofetal development

Michela Reina, Maria Luisa Broccia, Elena Menegola, Anna Maria Di Blasio, Paola Viganò, Erminio Giavini

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Problem: The immunological success of pregnancy is thought to depend upon the establishment of a balance between favorable and deleterious cytokines, the current paradigm viewing pregnancy as a T helper (Th)2 cytokine-dependent phenomenon. In this context, a particular attention should be directed to the potential role of interleukin (IL)-12, which promotes the development of Th1 responses, in the induction of adverse pregnancy-related phenomena. Indeed, very few data linked the Th1-inducer IL-12 to the event of abortion. Methods: In this study, we have investigated the maternal and fetal effects of exogenous administration of IL-12 to CD1 (BR) ICR mice during the pre- and peri-implantation period (day 2-6 of pregnancy). Animals have been evaluated for parameters of reproductive performance, embryo and fetal developmental toxicity and maternal toxicity. Results: Intraperitoneal administration of IL-12 at concentrations from 2.5 to 10 μg/kg daily did not result in an increase in the murine abortion rate. A statistically significant, although minimal, decrease in the number of somites were found in the embryos of animals treated with IL-12 at a dose of 10 μg/kg/day. However, developmental parameters at birth were similar between the two groups of animals suggesting that alteration of somites might be a transitory state during treatment. An increased body weight gains and reduced feed and water consumption were observed in the mothers treated with the cytokine. Conclusion: In the present experimental conditions and in this specific strain of mice, IL-12 does not exert adverse effects on reproductive performance and induces an only modest harmful action on mothers and embryos.

Original languageEnglish
Pages (from-to)345-351
Number of pages7
JournalAmerican Journal of Reproductive Immunology
Volume51
Issue number5
Publication statusPublished - May 2004

Fingerprint

Interleukin-12
Pregnancy
Somites
Embryonic Structures
Cytokines
Inbred ICR Mouse
Induced Abortion
Drinking
Weight Gain
Body Weight
Mothers
Parturition

Keywords

  • Abortion
  • Interleukin-12
  • Murine gestation
  • T helper 1 responses

ASJC Scopus subject areas

  • Immunology
  • Obstetrics and Gynaecology

Cite this

Effects of interleukin-12 administration during the pre- and peri-implantation period on mouse embryofetal development. / Reina, Michela; Broccia, Maria Luisa; Menegola, Elena; Di Blasio, Anna Maria; Viganò, Paola; Giavini, Erminio.

In: American Journal of Reproductive Immunology, Vol. 51, No. 5, 05.2004, p. 345-351.

Research output: Contribution to journalArticle

@article{b00cb69dc4dd4719bda67fbfbc5ad4f0,
title = "Effects of interleukin-12 administration during the pre- and peri-implantation period on mouse embryofetal development",
abstract = "Problem: The immunological success of pregnancy is thought to depend upon the establishment of a balance between favorable and deleterious cytokines, the current paradigm viewing pregnancy as a T helper (Th)2 cytokine-dependent phenomenon. In this context, a particular attention should be directed to the potential role of interleukin (IL)-12, which promotes the development of Th1 responses, in the induction of adverse pregnancy-related phenomena. Indeed, very few data linked the Th1-inducer IL-12 to the event of abortion. Methods: In this study, we have investigated the maternal and fetal effects of exogenous administration of IL-12 to CD1 (BR) ICR mice during the pre- and peri-implantation period (day 2-6 of pregnancy). Animals have been evaluated for parameters of reproductive performance, embryo and fetal developmental toxicity and maternal toxicity. Results: Intraperitoneal administration of IL-12 at concentrations from 2.5 to 10 μg/kg daily did not result in an increase in the murine abortion rate. A statistically significant, although minimal, decrease in the number of somites were found in the embryos of animals treated with IL-12 at a dose of 10 μg/kg/day. However, developmental parameters at birth were similar between the two groups of animals suggesting that alteration of somites might be a transitory state during treatment. An increased body weight gains and reduced feed and water consumption were observed in the mothers treated with the cytokine. Conclusion: In the present experimental conditions and in this specific strain of mice, IL-12 does not exert adverse effects on reproductive performance and induces an only modest harmful action on mothers and embryos.",
keywords = "Abortion, Interleukin-12, Murine gestation, T helper 1 responses",
author = "Michela Reina and Broccia, {Maria Luisa} and Elena Menegola and {Di Blasio}, {Anna Maria} and Paola Vigan{\`o} and Erminio Giavini",
year = "2004",
month = "5",
language = "English",
volume = "51",
pages = "345--351",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Effects of interleukin-12 administration during the pre- and peri-implantation period on mouse embryofetal development

AU - Reina, Michela

AU - Broccia, Maria Luisa

AU - Menegola, Elena

AU - Di Blasio, Anna Maria

AU - Viganò, Paola

AU - Giavini, Erminio

PY - 2004/5

Y1 - 2004/5

N2 - Problem: The immunological success of pregnancy is thought to depend upon the establishment of a balance between favorable and deleterious cytokines, the current paradigm viewing pregnancy as a T helper (Th)2 cytokine-dependent phenomenon. In this context, a particular attention should be directed to the potential role of interleukin (IL)-12, which promotes the development of Th1 responses, in the induction of adverse pregnancy-related phenomena. Indeed, very few data linked the Th1-inducer IL-12 to the event of abortion. Methods: In this study, we have investigated the maternal and fetal effects of exogenous administration of IL-12 to CD1 (BR) ICR mice during the pre- and peri-implantation period (day 2-6 of pregnancy). Animals have been evaluated for parameters of reproductive performance, embryo and fetal developmental toxicity and maternal toxicity. Results: Intraperitoneal administration of IL-12 at concentrations from 2.5 to 10 μg/kg daily did not result in an increase in the murine abortion rate. A statistically significant, although minimal, decrease in the number of somites were found in the embryos of animals treated with IL-12 at a dose of 10 μg/kg/day. However, developmental parameters at birth were similar between the two groups of animals suggesting that alteration of somites might be a transitory state during treatment. An increased body weight gains and reduced feed and water consumption were observed in the mothers treated with the cytokine. Conclusion: In the present experimental conditions and in this specific strain of mice, IL-12 does not exert adverse effects on reproductive performance and induces an only modest harmful action on mothers and embryos.

AB - Problem: The immunological success of pregnancy is thought to depend upon the establishment of a balance between favorable and deleterious cytokines, the current paradigm viewing pregnancy as a T helper (Th)2 cytokine-dependent phenomenon. In this context, a particular attention should be directed to the potential role of interleukin (IL)-12, which promotes the development of Th1 responses, in the induction of adverse pregnancy-related phenomena. Indeed, very few data linked the Th1-inducer IL-12 to the event of abortion. Methods: In this study, we have investigated the maternal and fetal effects of exogenous administration of IL-12 to CD1 (BR) ICR mice during the pre- and peri-implantation period (day 2-6 of pregnancy). Animals have been evaluated for parameters of reproductive performance, embryo and fetal developmental toxicity and maternal toxicity. Results: Intraperitoneal administration of IL-12 at concentrations from 2.5 to 10 μg/kg daily did not result in an increase in the murine abortion rate. A statistically significant, although minimal, decrease in the number of somites were found in the embryos of animals treated with IL-12 at a dose of 10 μg/kg/day. However, developmental parameters at birth were similar between the two groups of animals suggesting that alteration of somites might be a transitory state during treatment. An increased body weight gains and reduced feed and water consumption were observed in the mothers treated with the cytokine. Conclusion: In the present experimental conditions and in this specific strain of mice, IL-12 does not exert adverse effects on reproductive performance and induces an only modest harmful action on mothers and embryos.

KW - Abortion

KW - Interleukin-12

KW - Murine gestation

KW - T helper 1 responses

UR - http://www.scopus.com/inward/record.url?scp=2942650297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942650297&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 345

EP - 351

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 1046-7408

IS - 5

ER -